Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering.TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
